U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 182

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:148742000
GRCh38:
Chr3:149024213
GYG1V257IPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Mar 22, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr3:148744703
GRCh38:
Chr3:149026916
GYG1D346Y, L255F, D329YInborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
Uncertain significance
(Jul 20, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr3:148714128
GRCh38:
Chr3:148996341
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Mar 18, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr3:148714542
GRCh38:
Chr3:148996755
GYG1I111TGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr3:148714639
GRCh38:
Chr3:148996852
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(May 9, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr3:148744547
GRCh38:
Chr3:149026760
GYG1E294Q, E277QInborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
Uncertain significance
(May 15, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr3:148741903
GRCh38:
Chr3:149024116
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(May 27, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr3:148727063
GRCh38:
Chr3:149009276
GYG1G161DPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Apr 23, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr3:148709451
GRCh38:
Chr3:148991664
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jan 21, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr3:148727178
GRCh38:
Chr3:149009391
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Dec 21, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr3:148744583
GRCh38:
Chr3:149026796
GYG1L215F, G306W, G289WGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr3:148714585
GRCh38:
Chr3:148996798
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jul 17, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr3:148744540
GRCh38:
Chr3:149026753
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Oct 17, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr3:148727072
GRCh38:
Chr3:149009285
GYG1Q164RGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Aug 1, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr3:148741864
GRCh38:
Chr3:149024077
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Feb 3, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr3:148741827
GRCh38:
Chr3:149024040
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Mar 26, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr3:148714283
GRCh38:
Chr3:148996496
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(May 11, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr3:148727178
GRCh38:
Chr3:149009391
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Apr 23, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr3:148727082
GRCh38:
Chr3:149009295
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Apr 12, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr3:148744620
GRCh38:
Chr3:149026833
GYG1R228W, S301L, S318LGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jul 3, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr3:148711977
GRCh38:
Chr3:148994190
GYG1A19VGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Feb 6, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr3:148744303
GRCh38:
Chr3:149026516
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Jan 18, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr3:148714269
GRCh38:
Chr3:148996482
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jul 23, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr3:148714528
GRCh38:
Chr3:148996741
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVPathogenic
(Mar 12, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr3:148714196
GRCh38:
Chr3:148996409
GYG1L84PInborn genetic diseases, Polyglucosan body myopathy type 2, Glycogen storage disease XV
Uncertain significance
(Jun 1, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr3:148714217
GRCh38:
Chr3:148996430
GYG1S91LPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Mar 14, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr3:148714621
GRCh38:
Chr3:148996834
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jun 2, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr3:148744261
GRCh38:
Chr3:149026474
GYG1L284RPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Jan 10, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr3:148711916
GRCh38:
Chr3:148994129
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jul 6, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr3:148714650
GRCh38:
Chr3:148996863
GYG1N147SGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jul 21, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr3:148744621
GRCh38:
Chr3:149026834
GYG1R228QPolyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Aug 9, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr3:148744285
GRCh38:
Chr3:149026498
GYG1R292TPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Jul 3, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr3:148712036
GRCh38:
Chr3:148994249
GYG1A39TPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr3:148714559-148714560
GRCh38:
Chr3:148996772-148996773
GYG1E118fsGlycogen storage disease XV, Polyglucosan body myopathy type 2Pathogenic
(Aug 26, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr3:148712003
GRCh38:
Chr3:148994216
GYG1Q28*Polyglucosan body myopathy type 2, Glycogen storage disease XVPathogenic
(Oct 10, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr3:148744563
GRCh38:
Chr3:149026776
GYG1A282V, P209S, A299VGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Apr 4, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr3:148744230
GRCh38:
Chr3:149026443
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Sep 27, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr3:148741899
GRCh38:
Chr3:149024112
GYG1T223IPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Mar 22, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr3:148714206
GRCh38:
Chr3:148996419
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Aug 11, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr3:148744600-148744608
GRCh38:
Chr3:149026813-149026821
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr3:148744568
GRCh38:
Chr3:149026781
GYG1S284P, S301PGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jul 6, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr3:148744253-148744254
GRCh38:
Chr3:149026466-149026467
GYG1Y282fsGlycogen storage disease XV, Polyglucosan body myopathy type 2Pathogenic
(Aug 6, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr3:148727110
GRCh38:
Chr3:149009323
GYG1T177AGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr3:148744638
GRCh38:
Chr3:149026851
GYG1D234N, R324Q, R307QGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(May 30, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr3:148742051
GRCh38:
Chr3:149024264
GYG1V274IGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Dec 30, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr3:148714105
GRCh38:
Chr3:148996318
GYG1V54FGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Mar 27, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr3:148742041
GRCh38:
Chr3:149024254
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Sep 13, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr3:148744528
GRCh38:
Chr3:149026741
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Jun 1, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr3:148712033
GRCh38:
Chr3:148994246
GYG1L38FGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Dec 25, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr3:148741983
GRCh38:
Chr3:149024196
GYG1N251IPolyglucosan body myopathy type 2, Glycogen storage disease XVUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr3:148711931
GRCh38:
Chr3:148994144
GYG1Q4*Polyglucosan body myopathy type 2, Glycogen storage disease XVPathogenic
(Oct 10, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr3:148714652
GRCh38:
Chr3:148996865
GYG1Q148KGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jun 2, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr3:148741829
GRCh38:
Chr3:149024042
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Mar 11, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr3:148709432
GRCh38:
Chr3:148991645
GYG1T2RGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Mar 14, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr3:148712067
GRCh38:
Chr3:148994280
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Dec 28, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr3:148742068
GRCh38:
Chr3:149024281
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Mar 25, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr3:148714218
GRCh38:
Chr3:148996431
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Jul 30, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr3:148727188
GRCh38:
Chr3:149009401
GYG1V203MGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Mar 28, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr3:148727180
GRCh38:
Chr3:149009393
GYG1A200VGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jun 26, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr3:148712083
GRCh38:
Chr3:148994296
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Dec 8, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr3:148741914
GRCh38:
Chr3:149024127
GYG1T228fsGlycogen storage disease XV, Polyglucosan body myopathy type 2Pathogenic
(Jul 23, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr3:148741846
GRCh38:
Chr3:149024059
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Sep 24, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr3:148741830
GRCh38:
Chr3:149024043
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Sep 24, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr3:148741877
GRCh38:
Chr3:149024090
GYG1R216*Glycogen storage disease XV, Polyglucosan body myopathy type 2, not provided
Pathogenic
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr3:148741981
GRCh38:
Chr3:149024194
GYG1W250CGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jul 26, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr3:148742019
GRCh38:
Chr3:149024232
GYG1Q263PGlycogen storage disease XV, Polyglucosan body myopathy type 2, not specified
Uncertain significance
(May 13, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr3:148727080
GRCh38:
Chr3:149009293
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Benign
(Apr 18, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr3:148727049
GRCh38:
Chr3:149009262
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Jun 1, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr3:148712050
GRCh38:
Chr3:148994263
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Apr 29, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr3:148711967
GRCh38:
Chr3:148994180
GYG1A16Tnot provided, Polyglucosan body myopathy type 2, Glycogen storage disease XV
Likely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr3:148714070
GRCh38:
Chr3:148996283
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Aug 9, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr3:148744305
GRCh38:
Chr3:149026518
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Dec 1, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr3:148711981
GRCh38:
Chr3:148994194
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Aug 1, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr3:148714239
GRCh38:
Chr3:148996452
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Oct 29, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr3:148714254
GRCh38:
Chr3:148996467
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Feb 1, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr3:148714119
GRCh38:
Chr3:148996332
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Oct 6, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr3:148714194
GRCh38:
Chr3:148996407
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Aug 24, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr3:148714197
GRCh38:
Chr3:148996410
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Oct 7, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr3:148744226
GRCh38:
Chr3:149026439
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Benign
(Aug 26, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr3:148741824
GRCh38:
Chr3:149024037
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(May 29, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr3:148712076
GRCh38:
Chr3:148994289
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Apr 23, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr3:148744222
GRCh38:
Chr3:149026435
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Apr 19, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr3:148744669
GRCh38:
Chr3:149026882
GYG1E244APolyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Nov 19, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr3:148744663
GRCh38:
Chr3:149026876
GYG1I242TGlycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Oct 13, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr3:148741894
GRCh38:
Chr3:149024107
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Aug 22, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr3:148714510
GRCh38:
Chr3:148996723
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Feb 3, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr3:148744609
GRCh38:
Chr3:149026822
GYG1R224HPolyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jun 9, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr3:148744585
GRCh38:
Chr3:149026798
GYG1G216EPolyglucosan body myopathy type 2, Glycogen storage disease XVLikely benign
(Jul 19, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr3:148711914
GRCh38:
Chr3:148994127
GYG1Glycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Jul 4, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr3:148744672
GRCh38:
Chr3:149026885
GYG1Q245PGlycogen storage disease XV, Polyglucosan body myopathy type 2Likely benign
(Feb 17, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr3:148714229
GRCh38:
Chr3:148996442
GYG1Y95CGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Aug 13, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr3:148714148
GRCh38:
Chr3:148996361
GYG1D68GGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Nov 1, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr3:148744676
GRCh38:
Chr3:149026889
GYG1S320T, S337TGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Oct 4, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr3:148714693
GRCh38:
Chr3:148996906
GYG1Polyglucosan body myopathy type 2, Glycogen storage disease XVLikely pathogenic
(Sep 30, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr3:148741986
GRCh38:
Chr3:149024199
GYG1I252TGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Oct 5, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr3:148709429
GRCh38:
Chr3:148991642
GYG1M1KGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr3:148712045
GRCh38:
Chr3:148994258
GYG1Q42KGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Jan 16, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr3:148741995
GRCh38:
Chr3:149024208
GYG1T255IGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr3:148711957
GRCh38:
Chr3:148994170
GYG1N12KGlycogen storage disease XV, Polyglucosan body myopathy type 2Uncertain significance
(Dec 2, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr3:148741878
GRCh38:
Chr3:149024091
GYG1R216QInborn genetic diseases, Glycogen storage disease XV, Polyglucosan body myopathy type 2
Uncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination